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Background: Explicit consideration of anticipated regret is not part of the standard shared decision-making
protocols. This pilot study aimed to compare decisions about a hypothetical surgery for breast cancer and
examined whether regret is a consideration in treatment decisions.
Methods: In this randomized experimental study, 184 healthy female volunteers were randomized to receive a
standard decision aid (control) or one with information on post-surgical regret (experimental). The main outcome
measures were the proportion of subjects choosing lumpectomy vs. mastectomy and the proportion reporting that
regret played a role in the decision made. We hypothesized that a greater proportion of the experimental group
(regret-incorporated decision aid) would make a surgical treatment preference that favored the less regret-inducing
option and that they would be more likely to consider regret in their decision-making process as compared to the
control group.
Results: A significantly greater proportion of the experimental group subjects reported regret played a role in their
decision-making process compared to the control counterparts (78 vs. 65 %; p = 0.039). Recipients of the regret-
incorporated experimental decision aid had a threefold increased odds of choosing the less regret-inducing surgery
(OR = 2.97; 95 % CI = 1.25, 7.09; p value = 0.014).
Conclusions: In this hypothetical context, the incorporation of regret in a decision aid for preference-sensitive
surgery impacted decision-making. This finding suggests that keying in on anticipated regret may be an important
element of shared decision-making strategies. Our results make a strong argument for applying this design and
pursuing further research in a surgical patient population.
Trial registration: Clinicaltrials.gov, NCT02563808.
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In recent years, the US health-care system has been
redefining itself as one that strives to be patient-
centered. Central to this idea is the belief that pa-
tients ought to be actively engaged in their health
care (Barry & Edgman-Levitan 2012). One approach
to accomplishing this goal is the use of “shared
decision-making,” in which physician and patient
share information in an attempt to improve the ex-
tent to which patients select treatments that match* Correspondence: lee.fleisher@uphs.upenn.edu
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It is thought that shared decision-making can improve
care and reduce costs and is encouraged and supported by
the Affordable Care Act (ACA) (Oshima & Emanuel
2013).
Shared decision-making may be particularly important
in clinical situations in which there is clinical equipoise,
i.e., there is no best treatment paradigm. In these
“preference-sensitive” conditions, the treatment choice
depends on the unique values of the patient (Wennberg
2002). Although the use of decision aids has been shown
to increase patient activation, improve knowledge, and
aid in the realistic perception of outcome, the size of the
effect varies across studies (Wennberg et al. 2010; Stacey
et al. 2011). Furthermore, randomized control trialsis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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vention,” “usual care,” or “alternate intervention” have
found current decision aids to be no better than com-
parisons in improving satisfaction with decision-making,
anxiety, health outcomes, or decisional regret (O’Connor
et al. 2009; Goel et al. 2001).
In the current model of shared decision-making, pa-
tients are asked to make surgical decisions in which the
risks of different outcomes are discussed and presented
numerically. However, multiple studies have documented
the public’s lack of the numerical skills essential to mak-
ing informed medical decisions (Reyna et al. 2009). In
the area of surgical treatment of breast cancer, external
forces such as celebrity treatment choice rather than evi-
dence can influence the desire for more aggressive treat-
ment. Nancy Reagan’s choice of mastectomy over
lumpectomy in the late 1980s (Lewin 1988; Nattinger
et al. 1998) and more recently Angelina Jolie’s decision
to have a prophylactic double mastectomy are two ex-
amples (Kamenova et al. 2014).
Recent psychological research has highlighted the role
of anticipated regret—the fear of “buyer’s remorse”—as
an important influence on individual choices across a
range of domains, including health care (Zeelenberg
1999; Simonson 1992; Nelissen et al. 2011). While
largely absent from past research on the design of deci-
sion aids, insights from research on anticipated regret
may hold promise as a potential means of improving
decision-making strategies.
In this study, we aimed to investigate whether surgical
treatment choices for breast cancer would differ based
on the decision aid the subjects were given. We hypoth-
esized that subjects given an experimental decision aid
which incorporated information about regret would be
more likely to make a surgical treatment preference that
was less regret-inducing and that they would be more
likely to consider regret in their decision-making process
as compared to subjects in the control group.
Methods
We conducted a randomized experimental pilot study
at the University of Pennsylvania among healthy fe-
male volunteers receiving decision aids for the surgi-
cal treatment of early-stage breast cancer. Early-stage
breast cancer was chosen because although it has
more than one treatment option available, there is lit-
tle medical evidence to suggest one treatment option
is superior to another. Consequently, the ultimate
treatment choice is informed by patient preference
and greatly influenced by shared decision-making
strategies. Furthermore, early-stage breast cancer can
be treated with increasingly invasive procedures, the
more invasive of which has been associated with high
rates of regret after surgery.We incorporated information about the rate at which
regret occurs after surgery into standard decision aids
for breast cancer and assigned volunteers to receive the
standard or regret-incorporated versions.
Study participants and materials
The study received International Review Board approval
through the University of Pennsylvania. A waiver for
written informed consent was approved. Study subjects
were healthy female volunteers, recruited through cam-
pus advertising, and offered a participant compensation
of US$5. Subject recruitment and participation occurred
in April 2013. There were no specific inclusion or exclu-
sion criteria.
Study participants received decision aids on surgery
for early-stage breast cancer (Additional files 1 and 2).
We created two versions of the decision aid: one based
on standard information and one that incorporated add-
itional information on the rates of regret after surgical
treatment. To develop the standard version, we relied on
existing decision aids developed by the Informed
Medical Decisions Foundation and selected those with
the highest scores for the content, development process,
and effectiveness criteria proposed by the International
Patient Decision Aids Standards (IPDAS) collaboration.
For the experimental version, we incorporated additional
information on the rates of regret after surgical treatment
found in the literature (Fernandes-Taylor & Bloom 2011;
Lantz et al. 2005). In a study of 449 women 5 years post
surgery for breast cancer, Fernandes-Taylor and Bloom
(Fernandes-Taylor & Bloom 2011) found the post-surgical
regret rate for mastectomy was 24.1 %. Lantz and col-
leagues (Lantz et al. 2005) reported a post-surgical regret
rate of 11.4 % among a sample of 1633 women that under-
went mastectomy as opposed to lumpectomy.
Data collection and analysis
All data collection occurred in the Wharton Behavioral
Lab (WBL) on the University of Pennsylvania campus.
The WBL was initially funded by the Wharton School in
Spring 2005. The primary goal of the WBL is to enhance
the research productivity of Wharton-affiliated faculty
by minimizing the operational costs, both time and
money, of conducting research. Each WBL session lasts
30 to 60 min. During a session, study subjects may
complete questionnaires, participate in online experi-
ments, or interact in groups.
For the present study, standard and regret rate-
incorporated decision aids for breast cancer were distrib-
uted to participants at random. All participants were
asked to complete an investigator-designed computer-
based survey about their treatment preferences for
breast cancer surgery, as presented in the decision aid.
Participants were asked to choose between lumpectomy
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role that anticipated regret played in this decision-
making process and which sections or statements in the
decision aid most influenced their choice for treatment.
Demographic data was collected via an online survey
platform that captured age, gender, and university affili-
ation. Descriptive statistics were calculated for demo-
graphic data, and the anticipated regret outcomes were
compared between the experimental and control groups
using the chi-square test. Frequency counts were per-
formed for each line of each decision aid and analyzed.
Referenced lines from the decision aids that used the
same words with different sentence structure were col-
lapsed and counted together.
Results
There were 189 subjects enrolled in this study. From this
sample, the data collected from five of the participants
were discarded due to procedural error in data collec-
tion. Of the 184 females receiving the breast cancer
decision aid, 96 received the control standard version
and 88 received the experimental anticipated regret-
incorporated version.
Descriptive statistics of 182 study participants are
available; two participants did not complete the demo-
graphic questions (Table 1). Participants were 22.0 yearsTable 1 Demographics of study subjects
All subjects (N = 182) Ex
Mean (SD) or N (%)
Age in years 22.0 (6.6) 21
Employment status
Full-time 13 (7.1) 4
Part-time 72 (39.6) 35
Unemployed 97 (53.3) 49
Academic affiliation
Undergraduate 153 (84.1) 72
Graduate 21 (11.5) 13
Staff 8 (4.4) 3
Ethnicity
White 54 (29.7) 24
Black 32 (17.6) 13
Asian/Pacific Islander 68 (37.3) 35
Hispanic 12 (6.6) 7
Declined to state 16 (8.8) 9
Citizenship
American citizen 155 (85.1) 69
Green card 20 (11.0) 13
No green card 2 (1.1) 1
Declined to state 5 (2.8) 5old on average and included undergraduates (86 %),
graduate students (9 %), university staff (3 %), and others
(2 %). The majority were unemployed (53.3 %), while
over a third worked part-time (39.6 %) and 7.1 % worked
full-time. There was a statistically significant difference
between the experimental and control groups in terms
of citizenship.
Quantitative data
The first outcome of interest was the difference in surgi-
cal treatment preference by the decision aid type (ex-
perimental vs. control). In the control group, which
received the standard version of the decision aid, 74 out
of 96 (77 %) subjects chose lumpectomy over mastec-
tomy, whereas in the experimental group that received
the regret-incorporated decision aid, 80 out of 88 (91 %)
subjects chose lumpectomy over mastectomy (p = 0.011).
Subjects in the experimental group had a threefold in-
creased odds of choosing the less regret-inducing sur-
gery (OR = 2.97; 95 % CI = 1.25, 7.09; p value = 0.014;
Table 2).
Our other outcome of interest was whether there was
a difference in consideration of regret during the
decision-making process between those who received
the experimental vs. the standard version of the decision
aid. In the experimental group, 69 out of 88 (78 %)perimental (N = 88) Control (N = 94) p value
.8 (5.9) 22.1 (7.2) 0.76
(4.5) 9 (9.6) 0.43
(39.8) 37 (39.3)
(55.7) 48 (51.1)
(81.8) 81 (86.2) 0.70
(14.8) 8 (8.5)
(3.4) 5 (5.3)









Table 2 Preferred surgical treatment and role of regret by decision aid received
Experimental (N = 88) Control (N = 96) p value
Treatment choice?
Lumpectomy (vs. mastectomy) 80 (91 %) 74 (77 %) 0.011
Did regret play a role in your decision-making process?
Yes (vs. no) 69 (78 %) 62 (65 %) 0.039
Odds of choosing lumpectomy (vs. mastectomy)
OR 95 % CI p value
Experimental group 2.97 1.24–7.09 0.014
Odds that regret was considered in decision
OR 95 % CI p value
Experimental group 1.99 1.03–3.84 0.04
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making process, compared to 62 out of 96 (65 %) in the
control group (p = 0.039). Subjects in the experimental
group had a twofold increased odds (OR = 1.99; 95 % CI
= 1.03, 3.84; p value = 0.04) of considering regret during
the decision-making process as compared to subjects in
the control group.
Qualitative data
In order to analyze the responses to the survey question
of “what part(s) of the brochure played a role in the de-
cision you made for your treatment choice,” we per-
formed frequency counts for the various sentences
reported. The top five most frequent sentences for each
decision aid (experimental vs. control) are presented in
Table 3. Whereas many of the top five sentences re-
ported by the control group were also among the top
five most often reported by the experimental group,
there was a difference in the order of importance: sen-
tences referencing regret displaced other sentences from
the control condition. This pattern demonstrated that
when participants are presented with information about
regret rates, this information becomes an important fac-
tor in their decision-making process.
Discussion
In this randomized experimental study, we demonstrated
that incorporating information about post-surgical regret
into decision aids for breast cancer was associated with
preferences toward a less regret-inducing surgical treat-
ment option and a higher probability of considering re-
gret during the decision-making process. These findings
suggest that there is the potential that activating subjects
to think pre-operatively about the states they may ru-
minate on post-operatively could inform the decision-
making process. The concept that anticipated regret can
be used to optimize decision-making behavior has been
given credibility by recent neurobiological studies and
neuroimaging data that have found a neural basis for theemotion of regret (Camille et al. 2004; Coricelli et al.
2005). Functional magnetic resonance imaging (fMRI)
data have confirmed that the emotion of regret is sub-
served by specific cerebral regions and have localized
processing to the orbitofrontal cortex (Chandrasekhar
et al. 2008). The same pattern of activity expressed dur-
ing the experience of regret has been demonstrated to
be expressed in the moments preceding decision-
making, suggesting that experienced regret and antici-
pated regret are mediated by the same neural circuitry
(Coricelli et al. 2005). Furthermore, these same brain
structures become active when learning of another indi-
vidual’s regretful outcome, suggesting that one is able to
incorporate this type of information into the decision-
making process as it reactivates the same neural regret
network (Canessa et al. 2011). Taken together, these neu-
roimaging studies provide a neurobiological basis for the
design of our experiment and place regret at the inter-
section of emotion and cognition and document its role
in decision behavior.
Currently, the rates of post-surgical regret and asso-
ciated morbidities represent an objective body of in-
formation that has been previously overlooked or, at
best, only sporadically employed by individual physi-
cians. The observation that patients continue to have
post-surgical regret rates as high as 47 % in areas of
preference-sensitive medicine suggests that there is
room for improvement in the way in which we cur-
rently help patients to navigate the decision-making
process (Sheehan et al. 2007). Incorporating antici-
pated regret into the process may be one way of
achieving this outcome. Further, it holds promise for
combatting one of the themes most often expressed
by patients experiencing regret: dissatisfaction with
information provided regarding treatment alternatives
and adverse side effects, which can cause patients to
later say “if only I had known….” Therefore, the pa-
tient may more appropriately choose wisely from the
perspective of satisfaction after the intervention.
Table 3 Qualitative data: top five most frequent responses by decision aid
Control group standard decision aid Experimental group regret-incorporated decision aid
Frequency Response Frequency Response
18 (19 %) With mastectomy, after 10 years, about 8 out
of 100 women will have local recurrence. With
lumpectomy and radiation, after 10 years, about
10 out of 100 women will have local recurrence
19 (22 %) With mastectomy, after 10 years, about 8 out
of 100 women who have will have local
recurrence. With lumpectomy and radiation,
after 10 years, about 10 out of 100 women
would have a local recurrence
16 (17 %) Mastectomy removes the entire breast 18 (20 %) If a woman undergoes mastectomy and is
unable to cope with the loss of her breast…
she may regret her decision to treat a cancer
that could also have been cured with
breast-conserving therapy. This regret
may be especially pertinent if she learns
that a similar woman with a similar cancer
chose lumpectomy with radiation and
continued to live cancer-free without the
same sacrifice to her appearance
10 (10 %) The chance of local recurrence is low after
mastectomy and slightly higher after
lumpectomy with radiation
17 (19 %) Lumpectomy saves the breast
9 (9 %) You will live the same length of time whether
you choose mastectomy or lumpectomy with
radiation
14 (16 %) 24.1 % of women choosing mastectomy have
regretted their decision afterwards
9 (9 %) Cancer that comes back in the breast after
lumpectomy can usually be successfully
treated with mastectomy
14 (16 %) You will live the same length of time whether
you choose mastectomy or lumpectomy
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making situation, receipt of the decision aid that keyed
in on anticipated regret was associated with the surgical
treatment option demonstrated to be less likely to in-
duce regret. The difference in preference between the
experimental and control groups is important given that
studies have suggested an association between post-
surgical regret and poorer health-related quality of life
(Hu et al. 2003). Of note, post-surgical regret does not
appear to be dependent on having a bad outcome, as it
has been shown to occur in patients that are equivalent
in clinical outcome measures (Schroeck et al. 2008). If
anticipated regret can help patients minimize the likeli-
hood of post-surgical regret, then it may also spare them
the decrease in quality of life with which it is associated.
Despite the implications of this study, there are several
limitations. Our results are limited by the hypothetical
nature for the population in which the study was tested.
Specifically, the study subjects were not personally facing
the need to make a decision about breast cancer surgery.
Further, the average age of participants in this study was
younger than the age at which breast cancers are most
often diagnosed (Hayat et al. 2007). Finally, our study
cohort was comprised of individuals with an education
beyond high school. Over 10 % were in a graduate de-
gree program, the remainder is in an undergraduate de-
gree program or on staff at the institution. Therefore,
although this design was useful in demonstrating feasi-
bility, the results are not immediately generalizable tothe intended surgical patient population with early-stage
breast cancer, a population with a more diverse educa-
tional level.
Despite these limitations, the results of this pilot study
make a strong argument for applying this design to a lar-
ger, relevant surgical patient population to further inves-
tigate the role of anticipated regret in shared medical
decision-making. Specifically, this study design should
be repeated in cancer patients at the time of diagnosis of
early-stage breast cancer. After randomization to receive
the standard or regret-incorporated versions of the deci-
sion aid, patients should be followed through their
decision-making process, treatment course, and post-
decisional state. Important results will include the surgical
treatment selected as well as the rates of post-decisional
regret. We believe that a decision process which incorpo-
rates anticipated regret could be accomplished in the sur-
geon’s office through collaboration between the surgeon,
anesthesiologist and primary caregiver as part of the con-
sent process.
The incorporation of shared decision-making strat-
egies into health care is becoming increasingly im-
portant with the passing of the ACA, especially in
light of Section 3506, which specifically encourages
their use and application. This section of the ACA es-
tablishes shared decision-making as an ideal means of
accommodating patient preferences and assuring that
care-delivered matches care-desired. Nevertheless, this
ideal is yet to be consistently reached with less than
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informed decision-making, (Braddock et al. 1999) and
little being done to promote shared decision-making
since the passing of the ACA. Assessing the success
of medical care is a hallmark of the ACA and should
include the assessment of patient-reported outcomes.
This includes both health-related quality of life as
well as satisfaction with care. We believe that the
quality of consent should be assessed and that incorp-
oration of anticipated regret will lead to increased sat-
isfaction and trust.
Conclusions
Because patient decision aids are yet to be widely imple-
mented, we are uniquely poised to affect the future of
the shared decision-making process. The results of this
pilot study suggest that incorporation of regret rates into
decision aids might be a potential strategy to encourage
patients to think more elaborately before making a
choice. Anticipated regret may be an important element
of physician-patient decision-making capable of improv-
ing the quality of medical decisions and, in turn, the
value of health care delivered. Our results make a strong
argument for applying this design to a larger, relevant
population to investigate the validity of these findings
and their potential for improving shared decision-making
strategies.
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